Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;58(6):421-8.
doi: 10.4103/0019-5154.119947.

Role of histamine as a toxic mediator in the pathogenesis of vitiligo

Salil Kumar Panja  1 , Biman Bhattacharya, Sitesh Chandra Lahiri
Affiliations

Role of histamine as a toxic mediator in the pathogenesis of vitiligo

Salil Kumar Panja et al. Indian J Dermatol. 2013 Nov.

Abstract

Background: The precise cause of vitiligo is still unclear. Multiple theories have been proposed, including genetic, autoimmune, neural, and biochemical mechanisms. An immune mediated pathogenesis is indeed the most popular theory. The autoimmune hypothesis considers the role of toxic mediator that might cause an injury to the melanocytes with the release of an antigenic substance and subsequent autoimmunization.

Aims: This study performed over a period of 10 years (February 1975 to June 1985) aims at exploring the role that histamine might play in the pathogenesis of vitiligo.

Materials and methods: Fifty patients with a particular type of vitiligo characterized by faint white patches occurring with significant pruritus and a history of atopy were selected and blood histamine levels were determined by Bio-Assay method.

Results: Blood histamine values of patients with vitiligo of short duration and with pruritus were significantly increased in comparison with values of matched controls.

Conclusion: Histamine appears to play a significant role in the pathogenesis of a particular type of vitiligo characterized by faint hypopigmented patches with significant itching.

Keywords: Autoimmunity; atopy; histamine; intolerance to melanizing agents; vitiligo.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Figures

Figure 1
Figure 1
Histamine value histogram
See this image and copyright information in PMC

References

    1. Nordlund JJ, Ortonne JP. Vitiligo vulgaris. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, editors. The Pigmentary System. Physiology and Pathophysiology. New York: Oxford University Press; 1998. pp. 513–51.
    1. Xu AE, Zhang DM, Wei XD, Huang B, Lu LJ. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo. Int J Dermatol. 2009;48:86–90. - PubMed
    1. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16:208–14. - PubMed
    1. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16:90–100. - PubMed
    1. Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrud B, Yecheskel G, et al. Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol. 1996;105:84–8. - PMC - PubMed

LinkOut - more resources